9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Eli Lilly and Company
ADC Therapeutics S.A.
Esperas Pharma Inc.
IGM Biosciences, Inc.
Cyteir Therapeutics, Inc.
Emory University
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
Altor BioScience
National Health Research Institutes, Taiwan
Dartmouth-Hitchcock Medical Center